Downregulation of routine serum inflammatory markers, reduced sweat chloride concentrations, as well as a significant reduction in both CF serum and stimulated PBMCs IL-18, IL-1β, TNF, and IL-6 levels. The gene discussed is IL6; the disease is cystic fibrosis.